Status:
COMPLETED
C-reactive Protein Levels Among Individuals With COVID-19
Lead Sponsor:
Henning Bliddal
Conditions:
Coronavirus Infection
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this multi-center study is to clarify the value of a CRP measurement for triage of patients initially presenting with light symptoms of the COVID-19 infection. Current recomm...
Eligibility Criteria
Inclusion
- A test for COVID-19 taken at the check point
- Signed, informed consent for blood test to be drawn for the Biobank
Exclusion
- Former admission to hospital for COVID-19
- Direct admission from check point.
Key Trial Info
Start Date :
May 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2021
Estimated Enrollment :
1006 Patients enrolled
Trial Details
Trial ID
NCT04373798
Start Date
May 4 2020
End Date
March 30 2021
Last Update
August 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Parker Institute, Frederiksberg Hospital
Copenhagen, Denmark, 2000